Novel transcript, sense intronic to AOPEP (ENSG00000296343)

ENSG00000296343 is annotated as a "novel transcript, sense intronic to AOPEP" and classified as an RNA gene rather than a protein-coding gene[1]. Therefore, it is not considered a canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor. The entry appears to refer to a non-coding RNA identified within an intron of the AOPEP gene; these kinds of transcripts are often detected in large-scale transcriptomics efforts, but most have unknown function and are not established as disease-relevant or druggable entities. There is currently no evidence of direct involvement in disease, interaction with drugs, or confirmed biological function. The main gene in this region, AOPEP, encodes a zinc-dependent aminopeptidase involved in proteolysis and has been implicated in rare forms of dystonia, not the transcript itself[3][5][7]. The information available suggests this is not a recognized therapeutic molecular target. Key notes: - The entry is not a recognized therapeutic target or well-characterized gene. - The designation as "novel transcript" and "sense intronic" indicates uncertainty and lack of established function or importance[1]. - AOPEP (the gene in whose intron this transcript is found) is a protein-coding gene involved in metabolism and has documented disease relevance, but that information is not directly applicable for this non-coding RNA transcript[3][5][7].

Other names

ENSG00000296343